(Q34762279)

4 August 2017

0 references

A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis (English)

1 reference

4 August 2017

0 references

hepatocellular carcinoma

1 reference

Cheng Xu

1

1 reference

4 August 2017

Zhehui Yan

series ordinal

2

1 reference

4 August 2017

Liang Zhou

series ordinal

3

1 reference

4 August 2017

Yuming Wang

series ordinal

4

1 reference

4 August 2017

publication date

7 June 2013

1 reference

Journal of Cancer Research and Clinical Oncology

4 August 2017

published in

1 reference

4 August 2017

volume

139

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

1417-1424

1 reference

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Hepatocellualar carcinoma serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Meta-analyses of diagnostic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Glypicans: proteoglycans with a surprise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Reporting of measures of accuracy in systematic reviews of diagnostic literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

DNA methylation in transcriptional repression of two differentially expressed X-linked genes, GPC3 and SYBL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Glypican-3 is overexpressed in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Sources of variation and bias in studies of diagnostic accuracy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Meta-DiSc: a software for meta-analysis of test accuracy data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1458-5

[Expression features of glypican-3 and its diagnostic and differential values in hepatocellular carcinoma]

21 January 2018

1 reference

12 December 2020

Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma

1 reference

12 December 2020

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

1 reference

12 December 2020

Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma

1 reference

12 December 2020

Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma.

1 reference

12 December 2020

Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma

1 reference

12 December 2020

Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma

1 reference

12 December 2020

Up-regulation of glypican-3 in human hepatocellular carcinoma.

1 reference

12 December 2020

[Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]

1 reference

12 December 2020

Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers

1 reference

12 December 2020

Simultaneous measurements of serum AFP, GPC-3 and HCCR for diagnosing hepatocellular carcinoma

1 reference

12 December 2020

[Assessment of serum GPC3 as a tumor marker for hepatocellular carcinoma and malignant melanoma]

1 reference

12 December 2020

Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR

1 reference

12 December 2020

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

12 December 2020

Serum Markers of Hepatocellular Carcinoma

1 reference

12 December 2020

Glypican-3 as a serum marker for hepatocellular carcinoma

1 reference

12 December 2020

Systematic review and meta-analysis of diagnostic and prognostic studies: a tutorial

1 reference

12 December 2020

The values and limitations of glypican-3 as a novel tumor marker for hepatocellular carcinoma from clinical and economic viewpoints

1 reference

12 December 2020

10.1007/S00432-013-1458-5

Identifiers

DOI

1 reference

release_z4o6y6crgrdlhhjvehwz6e53yu

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z4o6y6crgrdlhhjvehwz6e53yu

24 November 2022

mapped directly with Wikidata item

1 reference